World's Largest Resource for Cardiovascular Perfusion

+1 888-499-5672 Login

Risks vs. Benefits of the Off-Label Use of Recombinant Factor VIIa in the Cardiac Arena (EP Video)

Blood Management, Main Zone, Mobile Zone, Multimedia Zone, Perfusion Zone

1 min read

Epic Staffing

Leave a Reply Cancel reply

You must be logged in to post a comment.

You may also like

Main Zone, Mobile Zone, Perfusion Zone

Evidence-Based Medicine and Myocardial Protection – Where is the Evidence?

Cardioplegia selection should rely more on higher scientific research,

1 min read

Blood Management, Main Zone, Mobile Zone, Perfusion Zone

Argatroban as a Aubstitute of Heparin During Cardiopulmonary Bypass: A Safe Alternative?

The objective of this communication is to report our recent experience with this agent during cardiopulmonary bypass (CPB) and to review the cases previously published in order to better define indications, dosage, monitoring and limitations in cardiac surgery patients.

1 min read

Blood Management, Main Zone, Perfusion Zone

In Vitro Comparison of the New In-Line Monitor BMU 40 versus a Conventional Laboratory Analyzer

. The objective of this in vitro study was to compare a novel continuous in-line blood parameter monitoring system versus a reference laboratory analyzer.

1 min read